Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
J Laryngol Otol ; 133(2): 95-101, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30739608

ABSTRACT

OBJECTIVE: This study evaluated tumour necrosis factor-α, interleukins 10 and 12, and interferon-γ levels, peripheral blood mononuclear cells, and clusters of differentiation 17c and 86 expression in unilateral sudden sensorineural hearing loss. METHODS: Twenty-four patients with unilateral sudden sensorineural hearing loss, and 24 individuals with normal hearing and no history of sudden sensorineural hearing loss (who were attending the clinic for other problems), were enrolled. Peripheral blood mononuclear cells, and clusters of differentiation 11c and 86 were isolated and analysed. Plasma and supernatant levels of tumour necrosis factor-α, interferon-γ, and interleukins 10 and 12 were measured. RESULTS: There were no significant differences with respect to age and gender. Monocyte population, mean tumour necrosis factor-α level and cluster of differentiation 86 expression were significantly increased in the study group compared to the control group. However, interferon-γ and interleukin 12 levels were significantly decreased. The difference in mean interleukin 10 level was not significant. CONCLUSION: Increases in tumour necrosis factor-α level and monocyte population might play critical roles in sudden sensorineural hearing loss. This warrants detailed investigation and further studies on the role of dendritic cells in sudden sensorineural hearing loss.


Subject(s)
Cytokines/blood , Hearing Loss, Sensorineural/blood , Hearing Loss, Sudden/blood , Inflammation/blood , Leukocytes, Mononuclear/metabolism , Adult , Biomarkers/blood , Enzyme-Linked Immunosorbent Assay , Female , Flow Cytometry , Follow-Up Studies , Humans , Male , Middle Aged , Retrospective Studies
2.
Phys Rev Lett ; 118(12): 121802, 2017 Mar 24.
Article in English | MEDLINE | ID: mdl-28388195

ABSTRACT

An experiment to search for light sterile neutrinos is conducted at a reactor with a thermal power of 2.8 GW located at the Hanbit nuclear power complex. The search is done with a detector consisting of a ton of Gd-loaded liquid scintillator in a tendon gallery approximately 24 m from the reactor core. The measured antineutrino event rate is 1976 per day with a signal to background ratio of about 22. The shape of the antineutrino energy spectrum obtained from the eight-month data-taking period is compared with a hypothesis of oscillations due to active-sterile antineutrino mixing. No strong evidence of 3+1 neutrino oscillation is found. An excess around the 5 MeV prompt energy range is observed as seen in existing longer-baseline experiments. The mixing parameter sin^{2}2θ_{14} is limited up to less than 0.1 for Δm_{41}^{2} ranging from 0.2 to 2.3 eV^{2} with a 90% confidence level.

3.
Clin Otolaryngol ; 42(3): 661-667, 2017 Jun.
Article in English | MEDLINE | ID: mdl-27863036

ABSTRACT

OBJECTIVES: The purpose of this study was to identify delayed auditory maturation and the fate of premature infants who failed the newborn hearing screening (NHS) in neonatal intensive care unit. MATERIALS AND METHODS: A total of 1375 neonates underwent NHS using the transient evoked otoacoustic emission (TEOAE) in a tertiary hospital between 2007 and 2010 according to the Joint Committee on Infant Hearing guidelines. In addition, a structured telephone survey was given to caregivers of infants who were lost to follow-up NHS. Auditory steady-state response (ASSR) threshold and the threshold change in diagnostic test failures were analysed. RESULT: Among the 1375 NICU babies, 344 (25.0%) babies, 111 (9.7%) babies and 64 (4.6%) babies failed to pass the first TEOAE, second TEOAE and diagnostic ASSR, respectively. However, at the age of about 5 years, 12 (0.9%) infants showed permanent hearing loss (PHL). The ASSR threshold improved from 69.0 ± 19.7 dB to 52.9 ± 21.6 dB in <4 months (P < 0.001). Premature infants of <29 weeks of gestational age at birth showed higher referral (P = 0.003) rate at the first OAE test compared to the others, and the difference continued until the last follow-up. The odds ratio for the initial ASSR threshold >67.5 dB for PHL was 9.00 (95% confidence interval, 1.7-46.7). CONCLUSION: Most of first TEOAE screening failures (91.3%) showed normal hearing and speech development. Hearing levels in premature infants can improve over time, particularly in neonates with initial ASSR threshold <67.5 dB.


Subject(s)
Auditory Threshold/physiology , Evoked Potentials, Auditory, Brain Stem/physiology , Hearing/physiology , Infant, Premature, Diseases/diagnosis , Infant, Premature , Neonatal Screening/methods , Otoacoustic Emissions, Spontaneous/physiology , Deafness/diagnosis , Deafness/epidemiology , Deafness/physiopathology , Female , Gestational Age , Hearing Tests , Humans , Incidence , Infant, Newborn , Infant, Premature, Diseases/epidemiology , Infant, Premature, Diseases/physiopathology , Male , Republic of Korea/epidemiology , Retrospective Studies
4.
Transplant Proc ; 44(2): 445-7, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22410039

ABSTRACT

PURPOSE: Decreased inhalational anesthetic requirements during orthotopic liver transplantation (OLT) have been reported according to the severity of the pre-existent disease as well as decreased opioid requirements thereafter. The aim of the present study was to determine the relationship between postoperative opioid requirements and severity of liver disease among OLT patients. METHODS: We retrospectively reviewed 44 recipients who used intravenous fentanyl-based patient-controlled analgesia (PCA) after OLT from November 2009 to May 2010. The severity of liver disease was assessed using the model for end-stage liver disease (MELD) score. Recipients were divided into a low-MELD group (<20; n=30) and a high-MELD group (≥20; n=14). The amounts of PCA infusion and rescue opioid up to 3 postoperative days (POD) were compared between the 2 groups. The intensity of pain at rest and when coughing was assessed using visual analog scale (VAS) scores. RESULTS: The cumulative opioid requirements via PCA on POD 1, 2, and 3 were significantly lower in the high-MELD than the low-MELD group. The amounts of rescue opioid were similar between the 2 groups. However, the intensity of pain at both rest and when coughing on POD 1, 2, and 3 were significantly less severe in the high-MELD than the low-MELD group. CONCLUSIONS: OLT patients with high MELD scores required less postoperative opioids and experienced less pain than those with low scores. Therefore, postoperative pain control after OLT should be carefully titrated according to the severity of the liver disease.


Subject(s)
Analgesia, Patient-Controlled , Analgesics, Opioid/administration & dosage , Fentanyl/administration & dosage , Liver Diseases/surgery , Liver Transplantation/adverse effects , Pain, Postoperative/drug therapy , Chi-Square Distribution , Cough/complications , Female , Health Status Indicators , Humans , Infusions, Intravenous , Liver Diseases/diagnosis , Male , Middle Aged , Pain Measurement , Pain, Postoperative/diagnosis , Pain, Postoperative/etiology , Predictive Value of Tests , Republic of Korea , Retrospective Studies , Risk Assessment , Risk Factors , Severity of Illness Index , Time Factors , Treatment Outcome
5.
Opt Express ; 19 Suppl 4: A695-700, 2011 Jul 04.
Article in English | MEDLINE | ID: mdl-21747536

ABSTRACT

InGaN/sapphire-based photovoltaic (PV) cells with blue-band GaN/InGaN multiple-quantum-well absorption layers grown on patterned sapphire substrates were characterized under high concentrations up to 150-sun AM1.5G testing conditions. When the concentration ratio increased from 1 to 150 suns, the open-circuit voltage of the PV cells increased from 2.28 to 2.50 V. The peak power conversion efficiency (PCE) occurred at the 100-sun conditions, where the PV cells maintained the fill factor as high as 0.70 and exhibited a PCE of 2.23%. The results showed great potential of InGaN alloys for future high concentration photovoltaic applications.

6.
J Laryngol Otol ; 120(7): 553-5, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16526969

ABSTRACT

OBJECTIVE: We report our technique and results for endoscopy-aided CO2 laser therapy for the treatment of intractable granular myringitis, as an out-patient office procedure. MATERIALS AND METHODS: A total of 21 patients (14 women and seven men; mean age 32.6 years) were retrospectively reviewed, all of whom suffered from intractable granular myringitis and had undergone endoscopy-aided laser treatment. Granulation tissue was vaporized for one to two seconds with a CO2 laser (spot size 0.5-1 mm with a power setting of 5-10 W in continuous mode). The mean follow-up period was 11 months. RESULTS: Eighteen of the 21 patients (85 per cent) were cured after a single treatment. Three patients with the diffuse form of the disease required repeat laser treatments coupled with self-irrigation with a diluted vinegar solution. We noted no perforations of patients' tympanic membranes after laser vaporization. We also observed no recurrences over follow-up periods ranging from three months to 2.6 years. Our laser procedure produced no adverse effect on hearing thresholds, nor were any other complications observed. CONCLUSION: Our results suggest that endoscopy-aided CO2 laser ablation is a reliable and minimally invasive method associated with low rates of recurrence and a low incidence of complications. It can be conducted as an office procedure.


Subject(s)
Dermatitis/surgery , Ear Canal/surgery , Ear Diseases/surgery , Laser Therapy/methods , Tympanic Membrane/surgery , Adult , Auditory Threshold/physiology , Carbon Dioxide , Day Care, Medical/methods , Dermatitis/pathology , Ear Canal/pathology , Ear Diseases/pathology , Endoscopy/methods , Female , Humans , Laser Therapy/adverse effects , Male , Recurrence , Reoperation , Retrospective Studies , Treatment Outcome , Tympanic Membrane/pathology
7.
Rheumatology (Oxford) ; 45(6): 703-10, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16418198

ABSTRACT

OBJECTIVES: TNF-alpha, IL-1 and IL-6 are known to have primary roles in the pathogenesis of rheumatoid arthritis and other inflammatory diseases. The anti-rheumatic drug chloroquine has been shown to inhibit TNF-alpha, IL-1 and IL-6 production from mononuclear phagocytes. We examined the underlying mechanisms involved in the chloroquine-induced inhibition of cytokine production. METHODS: Human peripheral blood mononuclear cells and monocytes/macrophages and monocytic U-937 and THP-1 cells were stimulated with lipopolysaccharide, and TNF-alpha, IL-1beta and IL-6 production was measured by ELISA. Levels of mRNA were measured by northern blotting and reverse transcription-polymerase chain reaction. Synthesis of 26-kDa TNF-alpha precursor was measured by metabolic labelling and immunoprecipitation analysis. Transcription rate was determined by nuclear run-on assay. RESULTS: TNF-alpha release from the cells was inhibited by chloroquine, whereas the steady-state level of TNF-alpha mRNA and synthesis of 26-kDa TNF-alpha precursor were not changed by chloroquine. In contrast, chloroquine-induced inhibition of IL-1beta and IL-6 release was accompanied by a decrease in their steady-state mRNA levels. The transcription rates of the IL-1beta and IL-6 genes were not changed by chloroquine, whereas the stability of IL-1beta and IL-6 mRNA was decreased by chloroquine. Weak-base amines such as methylamine and ammonium chloride had no effect on the production of TNF-alpha, whereas they partially blocked the production of IL-1beta and IL-6. CONCLUSIONS: Our results indicate that chloroquine-mediated inhibition of TNF-alpha, IL-1beta and IL-6 synthesis occurs through different modes in lipopolysaccharide-stimulated human monocytes/macrophages: it blocks the conversion of cell-associated TNF-alpha precursor to mature soluble protein, whereas it reduces the levels of IL-1beta and IL-6 mRNA, at least in part, by decreasing their stability and by a pH-dependent mechanism.


Subject(s)
Antirheumatic Agents/pharmacology , Chloroquine/pharmacology , Cytokines/biosynthesis , Monocytes/drug effects , Cells, Cultured , Cytokines/genetics , Dose-Response Relationship, Drug , Gene Expression Regulation/drug effects , Humans , Interleukin-1/biosynthesis , Interleukin-1/genetics , Interleukin-6/biosynthesis , Interleukin-6/genetics , Lipopolysaccharides/immunology , Macrophages/drug effects , Macrophages/immunology , Monocytes/immunology , RNA, Messenger/genetics , Reverse Transcriptase Polymerase Chain Reaction/methods , Tumor Cells, Cultured , Tumor Necrosis Factor-alpha/biosynthesis , Tumor Necrosis Factor-alpha/genetics
8.
Clin Otolaryngol Allied Sci ; 29(4): 321-3, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15270816

ABSTRACT

The most frequently isolated organism in chronic suppurative otitis media (CSOM) is Pseudomonas aeruginosa. Ototopical ciprofloxacin has proven effectiveness against P. aeruginosa. The purpose of this study is to evaluate the patients with recurrent otorrhoea caused by CSOM that was unresponsive to topical ciprofloxacin. Eighty-eight patients (18-77 years of age) with otorrhoea due to CSOM were reviewed retrospectively. All of them were initially treated with ciprofloxacin eardrops but the otorrhoea failed to resolve. Bacteriological specimens were processed and identified with standard cultures. In vitro antimicrobial susceptibility of these bacterial isolates was assessed by an agar disc diffusion method. Isolates were tested against 16 antibiotics. Ciprofloxacin-resistant P. aeruginosa were isolated in all cases. Imipenem was the most sensitive antibiotic agent with an overall susceptibility rate of 96.5%, followed by amikacin (55.6%), piperacillin/tazobactam (37.5%) and ceftazidime (31.8%). In our series, ciprofloxacin-resistant P. aeruginosa is increasing recently. Continuous surveillance is necessary to monitor antimicrobial resistance and to guide antibacterial therapy.


Subject(s)
Anti-Infective Agents/pharmacology , Ciprofloxacin/pharmacology , Otitis Media, Suppurative/drug therapy , Pseudomonas Infections/drug therapy , Pseudomonas aeruginosa/drug effects , Adolescent , Adult , Aged , Anti-Infective Agents/administration & dosage , Anti-Infective Agents/therapeutic use , Chronic Disease , Ciprofloxacin/administration & dosage , Ciprofloxacin/therapeutic use , Drug Resistance, Bacterial , Female , Humans , Instillation, Drug , Male , Microbial Sensitivity Tests , Middle Aged , Otitis Media, Suppurative/microbiology , Pseudomonas Infections/microbiology , Pseudomonas aeruginosa/isolation & purification , Retrospective Studies
9.
Clin Otolaryngol Allied Sci ; 27(6): 509-11, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12472521

ABSTRACT

The creation of an open mastoid cavity changes the acoustic characteristics of the external ear. The aim of this study was to ascertain the acoustic change in the external auditory canal caused by an open mastoid cavity and to compare it with mastoid obliteration. The external ear resonance characteristics were measured in 40 normal adult ears, 20 ears with an open mastoid cavity and 40 ears with an obliterated mastoid. The measurement of resonance characteristics was performed using a real ear analyser. An open mastoid cavity changed the mean peak resonant frequency of the external ear from 2.1 kHz to 2.3 kHz (P < 0.02), with a mean attenuation of 8 dB SPL at 4 kHz. An obliterated mastoid produced higher resonance frequencies from 2.5 kHz to 2.8 kHz. The sound pressure gain of the external auditory canal with an open mastoid cavity was higher than with an obliterated mastoid. The author concludes that an open mastoid cavity can affect the resonance frequency, and that this effect is reduced by mastoid obliteration. Therefore, mastoid obliteration results in a more normal ear canal both anatomically and functionally.


Subject(s)
Ear Canal/physiopathology , Mastoid/surgery , Adult , Humans , Middle Aged
10.
Immunopharmacol Immunotoxicol ; 23(4): 555-63, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11792014

ABSTRACT

Elevated levels of immunoglobulin (Ig) E are associated with immediate-type allergic reactions. Jin-deuk-chal is the whole plant of Siegesbeckia orientalis (SO) sL Immunization of mice with small amounts of protein antigens on alum results in several fold increases in total plasma IgE, much of it specific for the immunizing antigen. In the present study, we investigated the effect of Siegesbeckia orientalis (SO) on IgE production. SO inhibited the plasma levels of IgE induced by antigens. The effects of SO on the interleukin (IL)-4-dependent IgE response by mouse whole spleen cells were studied. IL-4 dependent IgE production of lipopolysaccharide (LPS)-stimulated whole spleen cells was inhibited by SO. In addition, using U266B I human IgE-bearing B cells, we found that SO inhibited the production of IgE activated by LPS plus IL-4. These results suggest that SO have antiallergic activity by inhibition of IgE production from B cells.


Subject(s)
Asteraceae , B-Lymphocytes/drug effects , Immunoglobulin E/biosynthesis , Plant Extracts/pharmacology , Spleen/drug effects , Animals , B-Lymphocytes/immunology , Enzyme-Linked Immunosorbent Assay , Female , Humans , Interleukin-4/immunology , Lipopolysaccharides/pharmacology , Mice , Mice, Inbred ICR , Spleen/immunology , Tumor Cells, Cultured
11.
Immunopharmacol Immunotoxicol ; 23(4): 627-37, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11792021

ABSTRACT

The herbal formulation ALLERGINA has been used against allergic inflammation disease for generations, and still occupies an important place in traditional medicine in Korea. In this study, we investigated the effect of ALLERGINA by oral administration in mast cell-mediated anaphylaxis responses. ALLERGINA dose-dependently inhibited compound 48/48-induced systemic anaphylaxis with doses of 10(-2) to 5 g/kg 1 h before orally administered. Of special note, ALLERGINA inhibited systemic anaphylaxis completely with doses of 1 g/kg and 5 g/kg. ALLERGINA (1 g/kg) also inhibited passive cutaneous anaphylaxis by 84%. ALLERGINA dose-dependently inhibited histamine release from rat peritoneal mast cells. When ALLERGINA (0.01 mg/ ml) was added, ALLERGINA inhibited the production of tumor necrosis factor-alpha and interleukin-6, 80% and 26%, respectively in anti-dinitrophenyl IgE antibody-stimulated mast cells. Our studies provide evidence that ALLERGINA may be beneficial in the treatment of allergic inflammation diseases.


Subject(s)
Anaphylaxis/prevention & control , Mast Cells/drug effects , Mast Cells/immunology , Plant Extracts/pharmacology , Anaphylaxis/chemically induced , Animals , Cell Line , Dose-Response Relationship, Drug , Histamine Release/drug effects , Interleukin-6/biosynthesis , Mast Cells/metabolism , Mice , Mice, Inbred ICR , Passive Cutaneous Anaphylaxis/drug effects , Plant Extracts/administration & dosage , Rats , Rats, Wistar , Tumor Necrosis Factor-alpha/biosynthesis , gamma-Globulins
12.
Laryngoscope ; 107(7): 872-7, 1997 Jul.
Article in English | MEDLINE | ID: mdl-9217122

ABSTRACT

The efficacy of surgery in controlling infection in 272 tympanomastoidectomy procedures for chronic otitis media (COM) was assessed by means of a four-point rating scale that incorporated both symptoms and signs, such as the presence or absence of otorrhea and granulation tissue. Of the 272 procedures, 170 were performed for COM with cholesteatoma and 102 were for active COM with granulation tissue but no cholesteatoma. Forty-seven percent were primary procedures, and 53% were revisions. Minimum follow-up was 12 months for all cases, with a mean of 30 months. Adequate control of infection occurred in 248 (91%) of the 272 cases. Of the 24 cases (9%) that developed persistent infection, 10 were controlled with a combination of oral and topical antibiotics and/or delayed skin grafting in the office. Thus overall satisfactory control of infection was achieved in 258 of 272 cases (95%). The outcome was influenced by the diagnostic category of COM: COM with cholesteatoma did significantly better than COM with granulation tissue (P = 0.02). The outcome was not influenced by the following variables: primary versus revision surgery, canal wall-up versus canal wall-down surgery, and extent of disease. The results suggest that active COM with granulation tissue may be more difficult to control than COM with cholesteatoma.


Subject(s)
Ear, Middle/surgery , Mastoid/surgery , Otitis Media, Suppurative/surgery , Administration, Oral , Administration, Topical , Adult , Anti-Bacterial Agents/administration & dosage , Anti-Bacterial Agents/therapeutic use , Cholesteatoma, Middle Ear/pathology , Cholesteatoma, Middle Ear/prevention & control , Cholesteatoma, Middle Ear/surgery , Chronic Disease , Ear Canal/surgery , Female , Follow-Up Studies , Granulation Tissue/pathology , Humans , Male , Otitis Media, Suppurative/pathology , Otitis Media, Suppurative/prevention & control , Recurrence , Reoperation , Retrospective Studies , Skin Transplantation , Treatment Outcome
13.
Am J Otol ; 18(1): 15-25, 1997 Jan.
Article in English | MEDLINE | ID: mdl-8989947

ABSTRACT

The objective of this study was to describe the light microscopic pathology of labyrinthine fistulae in chronic otitis media (COM) in seven temporal bones and to discuss clinical and surgical implications. In COM, labyrinthine fistulae are usually caused by cholesteatoma, with the lateral semicircular canal being the most commonly affected site. Some fistulae are asymptomatic, whereas, others affect the auditory and vestibular systems to varying degrees. Surgical removal of cholesteatoma matrix over a fistula carries a risk of sensorineural hearing loss. Knowledge of the pathology of fistulae may provide a better understanding of their clinical manifestations and may allow a more rational approach to surgical management. The Massachusetts Eye and Ear Infirmary temporal bone collection contains 115 specimens with COM, of which seven specimens show pathologic fistulization of the bony labyrinth. Histologic sections from these seven bones were evaluated with respect to type of COM, location and size of fistula, changes in the inner ear adjacent to the fistula, middle ear and mastoid disease, and pathology in the vestibular and cochlear sense organs. The following conclusions are presented (a) Labyrinthine fistulae can be caused not only by cholesteatoma, but also by granulomatous COM without cholesteatoma and even by localized infection within a canal-down mastoid cavity. (b) Cholesteatoma matrix or inflammatory tissue usually becomes apposed to the endosteum or membranous labyrinth within the fistula. In most cases, reactive inner ear changes do not occur at the fistula site. Occasionally, there is thickening of the endosteum or chronic localized labyrinthitis. (c) Most bones do not show any alterations of the vestibular and cochlear sense organs. Occasionally, there is serous labyrinthitis, which might lead to partial sensorineural hearing loss. (d) A protective "walling-off" phenomenon in the labyrinth is not common. Therefore, if overwhelming infection or surgical trauma breaches the natural barriers of the endosteum/membranous labyrinth, then the fistula may allow rapid dissemination of infection throughout the inner ear.


Subject(s)
Ear, Inner/physiopathology , Ear, Inner/ultrastructure , Fistula/physiopathology , Otitis Media , Adolescent , Adult , Aged , Cholesteatoma/complications , Chronic Disease , Ear, Inner/surgery , Female , Fistula/etiology , Fistula/surgery , Humans , Male , Middle Aged , Otitis Media/complications , Otitis Media/physiopathology , Otitis Media/surgery , Semicircular Canals/physiopathology
SELECTION OF CITATIONS
SEARCH DETAIL
...